跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CLONAZEPAM TZF 2 MG COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
CLONAZEPAM TZF 2 MG COMPRIMIDOS EFG
Approved
STANDARD
CLONAZEPAM TZF 2 MG COMPRIMIDOS EFG
Tarchominskie Zaklady Farmaceutyczne Polfa S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 16, 2023
Approval ID
e5d16ac87a53c26e
Company
Tarchominskie Zaklady Farmaceutyczne Polfa S.A.
Type
Standard
Approval Details
Approval Id
e5d16ac87a53c26e
Drug Cima Aemps Name
CLONAZEPAM TZF 2 MG COMPRIMIDOS EFG
Register Number
88732
Holder Company Name
Tarchominskie Zaklady Farmaceutyczne Polfa S.A.
Marketing Company Name
Tarchominskie Zaklady Farmaceutyczne Polfa S.A.
Authorization Date
2023-03-16
Dosage Form
COMPRIMIDO
Dose
2 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración. Psicótropos
Commercialized
No
Company Name
Tarchominskie Zaklady Farmaceutyczne Polfa S.A.
Active Ingredients
CLONAZEPAM
2 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 16, 2023
Approval ID
e5d16ac87a53c26e
Type
Standard
Back to CIMA-AEMPS Approvals